Header
Commercialisation of intellectual property
   

Ventures


Partners
The University of Reading

UK Portfolio
Aberro
Acolyte Biomedica
Geomerics
InnoMatica
Kaloptics
NeuroTargets
Novocellus
Parsortix
Provexis
Synature

Ventures

ANGLE specialises in the commercialisation of intellectual property (IP) developed by universities, research organisations and corporates.

By combining experienced start-up managers with capital, ANGLE’s in-house Progeny® process satisfies the unique requirements of early-stage technology businesses. ANGLE creates, develops and operates new companies that are able to bridge the ‘credibility gap’ between sources of IP and the conventional investment community.

Strategic Partnerships:
Responding to an increasing market need amongst UK Universities for a private-sector partner to their commercialisation processes, ANGLE Ventures UK is currently moving from a transactional approach to Venture creation towards forming a number of long-term strategic partnerships with selected partners.

ANGLE is delighted to announce that it has signed a twenty year deal with its first strategic partner, The University of Reading. ANGLE is currently working towards signing further high-profile partners in the near future.

Progeny®: A unique approach
The Progeny® process draws on a diverse set of business methodologies in building a unique approach to early-stage investment. It provides ANGLE’s technology partners with the right package of skills, resources and experience to overcome the usual barriers to IP exploitation. Progeny® is focused on creating businesses that are designed to be sold to trade buyers. By deploying a project approach, Progeny® manages the risk and uncertainty of creating something new.

Progress Chart